Transplant center directory

The adult program is one of the leading centers for transplantation of patients with testicular/germ cell tumors. Clinical interests include immunotherapy and use of novel agents for treating patients with lymphoma and multiple myeloma. Research interests include haploidentical transplantation, adult cord blood transplantation, enhancement of post-transplant immune function, and graft vs host disease prevention and treatment. The pediatric program is the only stem cell transplant program in Indiana for children. Children treated include those with leukemia, solid tumors, immundeficiencies, sickle cell disease, other non-malignant conditions and rare genetic disorders. Research interests include graft vs. host disease and use of mesenchymal stromal cells for Fanconi Anemia. The Adult and Pediatric Programs are the first in Indiana to be certified to administer commercial CART-cell Therapy.

This center has been performing allogeneic transplants since 1985 and has been an NMDP/Be The Match transplant center since January 1988.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 226 patients.

The actual 1-year survival of these patients is 76.5%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.9% and 84.1%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.